Celyad: Some Questions For Management
- I recently covered Celyad, and I have quite a few questions about the company.
- I have tried to answer some of them here myself.
- The rest are addressed to management.
By Dr. Udaya K Maiya, MBBS, MD, DNB, DCCF-Paris
I recently covered Celyad (CYAD), a small Belgian company developing CAR-T therapy for solid tumors, and I have a few follow up questions. Some of these needs to be answered by management, but some I could probably answer.
The full post is available to investor members only. Subscribe here.